Nitroglycerin Controlled Release Tablets 2.6 mg, 6.5 mg, 9 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 2.6 mg, 6.5 mg, 9 mg
Reference Brands: Various Indian Brand Available
Category: Heart Disorder
Nitroglycerin Controlled Release Tablet is used to treat and prevent heart-related chest pain (angina). Angina occurs when the heart muscle is not getting enough blood. This medicine works by relaxing and widening blood vessels so blood can flow more easily to the heart.
Product Description:
Nitroglycerin Controlled Release Tablets are a cardiovascular medication designed for the prevention of angina pectoris (chest pain) in patients with coronary artery disease. The active ingredient, nitroglycerin, is a nitrate that works by releasing nitric oxide in the body, which relaxes and dilates blood vessels. This vasodilation improves blood flow to the heart muscle and reduces the heart’s workload, helping prevent episodes of angina.
Unlike sublingual tablets, controlled-release tablets are formulated to provide a gradual and sustained release of nitroglycerin over 12–24 hours. This ensures steady blood levels of the drug, allowing prolonged protection against angina attacks and reducing the need for frequent dosing. The tablets are available in various strengths, typically 2.5 mg, 6.5 mg, 9 mg, and 12 mg.
Nitroglycerin Controlled Release Tablets are administered orally, usually once or twice daily, under the supervision of a healthcare professional. They are widely used in clinical settings for long-term management of angina and are available globally in both branded and generic formulations, manufactured under strict GMP standards.
Nitroglycerin Controlled Release Tablets — third party manufacturing & bulk supply
Nitroglycerin Controlled Release Tablets 2.6 mg, 6.5 mg, 9 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Nitroglycerin Controlled Release Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Nitroglycerin Controlled Release Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Nitroglycerin Controlled Release Tablets are used for the prevention of angina pectoris (chest pain) in patients with coronary artery disease. Unlike sublingual tablets, controlled-release formulations provide a sustained release of nitroglycerin, helping to maintain steady blood levels and reduce the frequency of angina attacks over 12–24 hours.
These tablets contain nitroglycerin, a nitrate compound that releases nitric oxide in the body, causing vasodilation of blood vessels and reducing the heart’s workload. The controlled-release formulation ensures gradual absorption, providing prolonged therapeutic effects.
Common trade names include Minitran CR, Nitro-Dur CR, and Nitrolingual CR, along with multiple generic versions available worldwide.
Minitran CR is marketed by 3M, Nitro-Dur CR by Pfizer, and Nitrolingual CR by Novartis. Generic controlled-release tablets are produced by several pharmaceutical companies globally.
The generic name is nitroglycerin.
Brand names include Minitran CR, Nitro-Dur CR, Nitrolingual CR, and several regional generics.
It is manufactured in GMP-certified pharmaceutical facilities across the USA, Europe, India, and Latin America.
Related Products
Trandolapril
Strength:
0.5 mg, 1 mg, 2 mg
Form: Tablets
Reference Brands: Mavik (USA), Gopten (EU)
View Details
Tirofiban Hydrochloride
Strength:
2.5 mg/mL
Form: Injection
Reference Brands: Aggrastat (USA)
View Details
Selexipag
Strength:
200 mcg, 400 mcg, 600 mcg, 800 mcg, 1000 mcg, 1200 mcg, 1400 mcg, 1600 mcg
Form: Tablets / Injection
Reference Brands: Uptravi (USA/EU)
View Details
Edoxaban
Strength:
15 mg, 30 mg, 60 mg
Form: Tablets
Reference Brands: Savaysa (USA), Lixiana (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
